- Home
- Publications
- Publication Search
- Publication Details
Title
Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-12
DOI
10.3389/fonc.2018.00513
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The landscape of genomic alterations across childhood cancers
- (2018) Susanne N. Gröbner et al. NATURE
- Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
- (2018) Christopher W. Mount et al. NATURE MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neurotoxicity Associated with a High-Affinity GD2 CAR—Letter
- (2018) Robbie G. Majzner et al. Cancer Immunology Research
- A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children’s Oncology Group Study ANBL0931
- (2018) M. Fevzi Ozkaynak et al. Frontiers in Immunology
- Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma
- (2018) Zhongzhen Yi et al. Molecular Therapy-Methods & Clinical Development
- Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
- (2018) Xiaotu Ma et al. NATURE
- The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner
- (2018) Mette Ø. Agerbæk et al. Nature Communications
- CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
- (2018) Hannah M. Knochelmann et al. Frontiers in Immunology
- Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels
- (2017) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- 2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors
- (2017) Thorsten Simon et al. KLINISCHE PADIATRIE
- Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
- (2017) Hussein A Tawbi et al. LANCET ONCOLOGY
- Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-α2b in patients with metastatic melanoma
- (2017) Ahmad A. Tarhini et al. MELANOMA RESEARCH
- A Novel Therapeutic Strategy for Pancreatic Cancer: Targeting Cell Surface Glycan Using rBC2LC-N Lectin–Drug Conjugate (LDC)
- (2017) Osamu Shimomura et al. MOLECULAR CANCER THERAPEUTICS
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma
- (2017) Khun Visith Keu et al. Science Translational Medicine
- Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models
- (2017) Melinda Mata et al. Cancer Discovery
- GD2 expression in breast cancer
- (2017) Giulia Orsi et al. Oncotarget
- High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model
- (2017) Sarah A. Richman et al. Cancer Immunology Research
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
- (2016) Kole T. Roybal et al. CELL
- Optimized human CYP4B1 in combination with the alkylator prodrug 4-ipomeanol serves as a novel suicide gene system for adoptive T-cell therapies
- (2016) K Roellecke et al. GENE THERAPY
- Epigenetic regulation of ganglioside expression in neural stem cells and neuronal cells
- (2016) Yutaka Itokazu et al. GLYCOCONJUGATE JOURNAL
- Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
- (2016) Avery D. Posey et al. IMMUNITY
- Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
- (2016) Paulina J. Paszkiewicz et al. JOURNAL OF CLINICAL INVESTIGATION
- CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
- (2016) Cameron J. Turtle et al. JOURNAL OF CLINICAL INVESTIGATION
- Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility
- (2016) Thomas Mandel Clausen et al. MOLECULAR CANCER RESEARCH
- Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults
- (2016) Konstantin Dobrenkov et al. PEDIATRIC BLOOD & CANCER
- Glycolipid GD3 and GD3 synthase are key drivers for glioblastoma stem cells and tumorigenicity
- (2016) Shih-Chi Yeh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas
- (2016) A. H. Long et al. Cancer Immunology Research
- Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G
- (2016) Sareetha Kailayangiri et al. OncoImmunology
- Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation
- (2015) X. Zhou et al. BLOOD
- Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein
- (2015) Ali Salanti et al. CANCER CELL
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors
- (2015) M. S. Merchant et al. CLINICAL CANCER RESEARCH
- Expression of stage-specific embryonic antigen-4 (SSEA-4) defines spontaneous loss of epithelial phenotype in human solid tumor cells
- (2015) Kavitha Sivasubramaniyan et al. GLYCOBIOLOGY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies
- (2015) Walter Cacciavillano et al. PEDIATRIC BLOOD & CANCER
- Remote control of therapeutic T cells through a small molecule-gated chimeric receptor
- (2015) C.-Y. Wu et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- mTORC1 Maintains the Tumorigenicity of SSEA-4+ High-Grade Osteosarcoma
- (2015) Wu Zhang et al. Scientific Reports
- The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL
- (2015) Richard Beatson et al. PLoS One
- Immunoreactivity of the 14F7 Mab raised againstN-Glycolyl GM3 Ganglioside in retinoblastoma tumours
- (2014) Ana Vanesa Torbidoni et al. ACTA OPHTHALMOLOGICA
- A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy
- (2014) B. Philip et al. BLOOD
- Gangliosides Drive the Tumor Infiltration and Function of Myeloid-Derived Suppressor Cells
- (2014) A. Wondimu et al. CANCER RESEARCH
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Retargeting of Human T Cells to Tumor-Associated MUC1: The Evolution of a Chimeric Antigen Receptor
- (2014) S. Wilkie et al. JOURNAL OF IMMUNOLOGY
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- GD3 synthase regulates epithelial–mesenchymal transition and metastasis in breast cancer
- (2014) T R Sarkar et al. ONCOGENE
- Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers
- (2014) Y.-W. Lou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ewing sarcoma dissemination and response to T-cell therapy in mice assessed by whole-body magnetic resonance imaging
- (2013) L Liebsch et al. BRITISH JOURNAL OF CANCER
- Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma
- (2013) Michael Roth et al. CANCER
- Cell cycle arrest and apoptosis induced by O-acetyl-GD2-specific monoclonal antibody 8B6 inhibits tumor growth in vitro and in vivo
- (2013) Denis Cochonneau et al. CANCER LETTERS
- Epigenetic activation of mouse ganglioside synthase genes: implications for neurogenesis
- (2013) Yi-Tzang Tsai et al. JOURNAL OF NEUROCHEMISTRY
- Estradiol Represses the GD3 Synthase Gene ST8SIA1 Expression in Human Breast Cancer Cells by Preventing NFκB Binding to ST8SIA1 Promoter
- (2013) Marie Bobowski et al. PLoS One
- Generation of Murine Sympathoadrenergic Progenitor-Like Cells from Embryonic Stem Cells and Postnatal Adrenal Glands
- (2013) Shobhit Saxena et al. PLoS One
- PD-1- and CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses
- (2013) V. D. Fedorov et al. Science Translational Medicine
- Isolation of Small SSEA-4-Positive Putative Stem Cells from the Ovarian Surface Epithelium of Adult Human Ovaries by Two Different Methods
- (2013) Irma Virant-Klun et al. Biomed Research International
- Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
- (2013) G. L. Beatty et al. Cancer Immunology Research
- The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting
- (2012) S Kailayangiri et al. BRITISH JOURNAL OF CANCER
- Disialyl gangliosides enhance tumor phenotypes with differential modalities
- (2012) Koichi Furukawa et al. GLYCOCONJUGATE JOURNAL
- Surface markers in stem cells and cancer from the perspective of glycomic analysis
- (2012) Huan-Chieh Cho et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
- Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis
- (2012) Venkata Lokesh Battula et al. JOURNAL OF CLINICAL INVESTIGATION
- Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission
- (2012) Nai-Kong V. Cheung et al. JOURNAL OF CLINICAL ONCOLOGY
- Intratumoral hu14.18-IL-2 (IC) Induces Local and Systemic Antitumor Effects That Involve Both Activated T and NK Cells As Well As Enhanced IC Retention
- (2012) R. K. Yang et al. JOURNAL OF IMMUNOLOGY
- Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
- (2012) Christopher C Kloss et al. NATURE BIOTECHNOLOGY
- Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo
- (2012) Nai-Kong V. Cheung et al. OncoImmunology
- Expression of GD2 and GD3 Gangliosides in Human Embryonic Neural Stem Cells
- (2011) Makoto Yanagisawa et al. ASN Neuro
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- Human Xeno-Autoantibodies against a Non-Human Sialic Acid Serve as Novel Serum Biomarkers and Immunotherapeutics in Cancer
- (2011) V. Padler-Karavani et al. CANCER RESEARCH
- Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer
- (2011) Alejandra M. Scursoni et al. Clinical & Developmental Immunology
- Histone acetylation-mediated glycosyltransferase gene regulation in mouse brain during development
- (2011) Yusuke Suzuki et al. JOURNAL OF NEUROCHEMISTRY
- Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport
- (2011) Kazuaki Ohtsubo et al. NATURE MEDICINE
- A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity
- (2011) Nidia Alvarez-Rueda et al. PLoS One
- Anti-GD3 Chimeric sFv-CD28/T-Cell Receptor Designer T Cells for Treatment of Metastatic Melanoma and Other Neuroectodermal Tumors
- (2010) A. S. Y. Lo et al. CLINICAL CANCER RESEARCH
- Shedding of GD2 ganglioside in patients with retinoblastoma
- (2010) Jacques Portoukalian et al. INTERNATIONAL JOURNAL OF CANCER
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-GD2 with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia
- (2010) Linda S. Sorkin et al. PAIN
- Comparative Analysis of the Membrane Proteome of Closely Related Metastatic and Nonmetastatic Tumor Cells
- (2009) Christoph Roesli et al. CANCER RESEARCH
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- High-Throughput Analysis of Gangliosides in Defined Regions of Fetal Brain by Fully Automated Chip-Based Nanoelectrospray Ionization Multi-Stage Mass Spectrometry
- (2009) Alina Serb et al. EUROPEAN JOURNAL OF MASS SPECTROMETRY
- Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction
- (2009) Elena Posse de Chaves et al. FEBS LETTERS
- Reducing Epitope Spread during Affinity Maturation of an Anti-Ganglioside GD2 Antibody
- (2009) J. Hu et al. JOURNAL OF IMMUNOLOGY
- The Lewis-Y Carbohydrate Antigen is Expressed by Many Human Tumors and Can Serve as a Target for Genetically Redirected T cells Despite the Presence of Soluble Antigen in Serum
- (2009) Jennifer A. Westwood et al. JOURNAL OF IMMUNOTHERAPY
- Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study
- (2009) Fabio Ciceri et al. LANCET ONCOLOGY
- Valproic acid induces transcriptional activation of human GD3 synthase (hST8Sia I) in SK-N-BE(2)-C human neuroblastoma cells
- (2009) Haw-Young Kwon et al. MOLECULES AND CELLS
- High-throughput screening of cell lysates for ganglioside synthesis
- (2008) Susan M. Hancock et al. ANALYTICAL BIOCHEMISTRY
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
- (2008) Martin A Pule et al. NATURE MEDICINE
- Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway
- (2008) A. R. Todeschini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started